Concepedia

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial

James W. Denham, David Joseph, David S. Lamb, Nigel Spry, Gillian Duchesne, John Matthews, Chris Atkinson, Keen‐Hun Tai, David Christie, Liz Kenny,

The Lancet Oncology · 2018 · 106 citations · 24 references

DOIFull text

Open access

Concepts

References

24

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

N.K. Aaronson, Sam H. Ahmedzai, Bengt Bergman et al. · JNCI Journal of the National Cancer Institute · 1993 · 16K citations

, , +15

A Proportional Hazards Model for the Subdistribution of a Competing Risk

Jason P. Fine · Journal of the American Statistical Association · 1999 · 13.6K citations

, , +15

Interpreting the significance of changes in health-related quality-of-life scores.

David Osoba, George Rodrigues, James D. Myles et al. · Journal of Clinical Oncology · 1998 · 2.9K citations

, , +16

EORTC QLQ-C30 Scoring Manual

Peter Fayers, Neil K. Aaronson, Kristin Bjordal et al. · Research at the University of Copenhagen (University of Copenhagen) · 1995 · 2.4K citations

, , +2

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

M. Bolla, Dionisio González, Padraig Warde et al. · New England Journal of Medicine · 1997 · 1.6K citations · Full text

, , +15